Linezolid Stada

Linezolid, the active ingredient in Linezolid Stada, is a oxazolidinone antibiotic presented as an oral formulation for oral use. It treats infections caused by susceptible Gram‑positive bacteria, including MRSA and VRE, in adult patients. GNH USA supplies Linezolid Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid Stada is an oxazolidinone antibiotic used to treat serious Gram‑positive bacterial infections. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: eradicates resistant skin, soft‑tissue and bloodstream infections. - Vancomycin‑resistant Enterococcus (VRE) infections: provides an effective oral option for resistant enterococcal disease. - Community‑acquired bacterial pneumonia: treats pneumonia caused by susceptible Gram‑positive organisms. - Skin and soft‑tissue infections caused by susceptible Gram‑positive bacteria: resolves cellulitis, abscesses and wound infections.

Linezolid may cause a range of adverse reactions, ranging from mild to serious.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, usually self‑limiting. - Headache: transient cranial discomfort. - Metallic taste: altered taste perception. - Myelosuppression: mild reduction in blood cell counts.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: nerve damage causing tingling or numbness. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance. - Vision changes: blurred or decreased visual acuity.

Before prescribing Linezolid Stada, consider the following safety measures. - Renal function monitoring: assess kidney status in patients with impairment. - Hepatic function monitoring: evaluate liver enzymes periodically. - Hematologic monitoring: perform complete blood counts to detect myelosuppression. - Hypersensitivity caution: avoid in patients with known allergy to linezolid or oxazolidinones. - Serotonergic drug caution: assess risk of serotonin syndrome when co‑administered. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Linezolid Stada can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Serotonergic agents (SSRIs, SNRIs, Tricyclic antidepressants): potential serotonin syndrome.

Moderate Interactions (Monitor Closely): - Rifampin: may reduce linezolid plasma concentrations. - Antacids containing magnesium or aluminum: may affect absorption. - Warfarin: monitor INR for possible increased anticoagulant effect.